Concepedia

Irina Yurgelonis

IY

Statistics

Publications

7

Citations

295

H-Index

7

Active since

2013

Affiliations

Pfizer (United States)(Current)

Irina Yurgelonis is an author at Pfizer (United States) specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2013–2024

7

Publications

7

A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile

Robert G. K. Donald, Mike Flint, Narender K. Kalyan et al. · Microbiology · 2013 · 92 citations · Full text

, , +16

A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Charlotte Allerton, Joel T. Arcari, Lisa Aschenbrenner et al. · Journal of Medicinal Chemistry · 2024 · 59 citations · Full text

Discovery of SARS-CoV-2 papain-like protease (PL <sup>pro</sup> ) inhibitors with efficacy in a murine infection model

Michelle R. Garnsey, Matthew C. Robinson, Luong T. Nguyen et al. · Science Advances · 2024 · 38 citations · Full text

In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance

Yuao Zhu, Irina Yurgelonis, Stephen Noell et al. · Science Advances · 2024 · 34 citations · Full text

Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern

K. Devendra, Irina Yurgelonis, Patricia McMonagle et al. · 2022 · 33 citations · Full text

, , +21

1–5 of 7